Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H E Connor

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Cephalalgia : an International Journal of Headache|May 1, 1997
Naratriptan: biological profile in animal models relevant to migraineH E Connor, W Feniuk, D T Beattie, et al.
British Journal of Pharmacology|December 1, 1995
The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonistD T Beattie, I J Beresford, H E Connor, et al.
Journal of Medicinal Chemistry|July 22, 1994
Evolution of a novel series of [(N,N-dimethylamino)propyl]- and piperazinylbenzanilides as the first selective 5-HT1D antagonistsJ W Clitherow, D I Scopes, M Skingle, et al.
British Journal of Pharmacology|October 26, 2011
Pharmacological characterization of GSK1004723, a novel, long-acting antagonist at histamine H(1) and H(3) receptorsR J Slack, L J Russell, D A Hall, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Cephalalgia : an International Journal of Headache|May 1, 1997
Naratriptan: biological profile in animal models relevant to migraineH E Connor, W Feniuk, D T Beattie, et al.
British Journal of Pharmacology|December 1, 1995
The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonistD T Beattie, I J Beresford, H E Connor, et al.
Journal of Medicinal Chemistry|July 22, 1994
Evolution of a novel series of [(N,N-dimethylamino)propyl]- and piperazinylbenzanilides as the first selective 5-HT1D antagonistsJ W Clitherow, D I Scopes, M Skingle, et al.
British Journal of Pharmacology|October 26, 2011
Pharmacological characterization of GSK1004723, a novel, long-acting antagonist at histamine H(1) and H(3) receptorsR J Slack, L J Russell, D A Hall, et al.
Pageof 6